LENZ

LENZ Therapeutics, Inc. · NASDAQ

Performance

-9.12%

1W

-3.17%

1M

+40.39%

3M

+117.97%

6M

+96.94%

YTD

+129.33%

1Y

Profile

LENZ Therapeutics, Inc. develops ophthalmic pharmaceutical products. The company develops LNZ100 and LNZ101 which are aceclidine-based eye drops designed to correct the loss of near vision associated with presbyopia. The company develops eye drops that help restore the loss of near vision associated with presbyopia, enabling patients to get an on-demand, rapid-acting, and safe treatment option. LENZ Therapeutics, Inc. was formerly known as Presbyopia Therapies, Inc. and changed its name to LENZ Therapeutics, Inc. in June 2021. The company was incorporated in 2013 and is based in Del Mar, California.

Technical Analysis of LENZ 2024-12-10

The stock's indicators reflect a neutral sentiment, with the Moving Average Score at 56 indicating a slight bullish tendency, while the Oscillators Score remains neutral at 50, and the overall Technical Score at 53 suggests a balanced outlook. This combination implies that while there is some upward momentum, caution is warranted as the market s...
Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

See more ...

Stock Analysis of LENZ

Stock Rank

See more ...

Recent News & Updates

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.